<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A19DEFFA-FECA-4E87-B8C6-A2BC9F43550F"><gtr:id>A19DEFFA-FECA-4E87-B8C6-A2BC9F43550F</gtr:id><gtr:name>Epistem</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Inst of Infections and Immunity</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A19DEFFA-FECA-4E87-B8C6-A2BC9F43550F"><gtr:id>A19DEFFA-FECA-4E87-B8C6-A2BC9F43550F</gtr:id><gtr:name>Epistem</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6DAD9590-C04A-4CBE-8340-EF969F6AED47"><gtr:id>6DAD9590-C04A-4CBE-8340-EF969F6AED47</gtr:id><gtr:firstName>Fred</gtr:firstName><gtr:surname>Sablitzky</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7A630908-5B65-4D8F-82DD-0267594525AD"><gtr:id>7A630908-5B65-4D8F-82DD-0267594525AD</gtr:id><gtr:firstName>Yashwant</gtr:firstName><gtr:surname>Mahida</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BDB09E7D-BC35-4D34-AF36-B9617AE461D7"><gtr:id>BDB09E7D-BC35-4D34-AF36-B9617AE461D7</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>Stanislaus</gtr:otherNames><gtr:surname>Potten</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500067"><gtr:id>20FE6D38-D829-4B80-B658-0BF9DC5C59C8</gtr:id><gtr:title>Gastrointestinal stem cells and their progeny in health and disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500067</gtr:grantReference><gtr:abstractText>Our research will study stem cells of the epithelium that lines the intestine. The epithelium is important in protecting the intestine against inflammatory diseases such as ulcerative colitis, Crohn?s disease or those due to infection. Acute inflammation can arise due to infection by bacteria and usually resolves without any long term harm. Chronic inflammatory diseases have more complex causes in which genes that determine how we respond to bacteria normally resident in the intestine appear to be important. Currently, there is no medical cure for ulcerative colitis or Crohn?s disease. These diseases often require long-term medical treatment or surgery and there is also an increased risk of the development of cancer, which arises from the epithelium. It is postulated that abnormalities in the ways in which the epithelial stem cells and their daughter cells interact with bacteria normally resident in the intestine, and the neighbouring cells in the lining of the intestine, lead to chronic inflammation. Our research will involve the study of stem cells in specimens of normal and diseased human intestine and also in mouse models. It is hoped that the outcome of the programme of research will be better understanding of the regulation of the epithelium and its stem cells and how abnormalities of their function may lead to intestinal inflammation. Greater understanding of adult epithelial stem cells may also enable the development of future methods for their manipulation in the laboratory such that they can subsequently be useful for treatment.</gtr:abstractText><gtr:technicalSummary>The main focus of the proposed research is a study of the mucosal epithelial stem cells and their differentiated progeny that mediate distinct functions in the small and large intestine. Inflammatory disease of the human intestine, whether acute and infection-induced (as in C. difficile-induced colitis) or chronic as in the inflammatory bowel diseases is seen as a consequence of defective epithelial function, arising because of altered secretion of protective components or because of altered permeability. It is suggest that these alterations may arise as a consequence of dysregulated responses by epithelial stem cells to products of luminal commensal or pathogenic microorganisms and signals from neighbouring mucosal cells, especially subepithelial myofibroblasts, which have been implicated in Wnt signalling. The experimental studies will use human mucosal cells from patient material and mouse models to investigate properties of epithelial stem cells under steady state conditions and in inflammatory diseases of the intestine. Our unique ex-vivo model will be used to isolate human intestinal epithelial stem cells and components of their niche. Novel in vitro culture conditions will be established to investigate the regulation of stem cells by Wnt (and related) signals and purified bacterial products. The contribution of host receptors for microbial constituents will be characterised. This will include products of the NOD2 gene, which is mutated in some patients with Crohn?s disease. Work in mouse models will study genome protective mechanisms dysregulation of which may lead to the increased risk of cancer seen in the chronically inflamed colon. A transgenic mouse model will be established to enable in vivo labelling and study of gastrointestinal stem cells in normal and inflamed intestine. It is anticipated that, in addition to new insights into the aetiopathogenesis of inflammatory diseases of the intestine, the above studies will lead to greater understanding of the intrinsic properties of intestinal epithelial stem cells that will facilitate future investigation of their potential for use in regenerative medicine.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>651204</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Epistem</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Biotechnology company</gtr:description><gtr:id>78D60E23-8185-4A18-A2C6-BF95EBD83414</gtr:id><gtr:impact>Joint publication: Potten CS, Gandara R, Mahida YR, Loeffler M, &amp;amp; Wright NA. The stem cells of small intestinal crypts; where are they? Cell Prolif. 2009;42(6):731-50.

Joint PhD studentship.</gtr:impact><gtr:outcomeId>AF6B782225D-1</gtr:outcomeId><gtr:partnerContribution>Expertise in specific research techniques.</gtr:partnerContribution><gtr:piContribution>Scientific discussions, provision of samples/materials.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation at Physicians meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8D80E64D-5E00-4B40-8FB6-664063FFE7A5</gtr:id><gtr:impact>Physicians, including trainees.

Discussions with clinical trainees with an interest in research.</gtr:impact><gtr:outcomeId>5F625AC4EE5</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AE0284CD-4940-494C-996C-97298FC589D8</gtr:id><gtr:impact>Presentation to Nottinghamshire National Association for Colitis and Crohn's Disease Group

Discussed value of research undertaken using patient samples.</gtr:impact><gtr:outcomeId>2ABDC063DC2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Unit, Nottingham University Hospitals NHS Trust</gtr:department><gtr:description>Nottingham Digestive Diseases Centre Biomedical Research Unit (NDDC BRU)</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>EE5CF388-26AD-4ADB-A620-F42EC8B4DED6</gtr:id><gtr:outcomeId>11BF8CDD23B0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>208000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Training Fellowship</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>AEB3F506-F9FD-492F-A00C-1DB7B2501827</gtr:id><gtr:outcomeId>969ECD48FB90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>Portugal, Portuguese Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Government of the Portugese Republic</gtr:fundingOrg><gtr:id>CE3FBE3A-23D5-465E-917C-8BF8FACE17C6</gtr:id><gtr:outcomeId>1163FD9328D0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CF84884A-DE8C-4A39-AF1C-A921C0ACDE34</gtr:id><gtr:title>Epithelial stem cell-related alterations in Trichinella spiralis-infected small intestine.</gtr:title><gtr:parentPublicationTitle>Cell proliferation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da1418e5f15e3c91657abbb6db828597"><gtr:id>da1418e5f15e3c91657abbb6db828597</gtr:id><gtr:otherNames>Walsh R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-7722</gtr:issn><gtr:outcomeId>C4960CEF5FA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98B70518-58B6-4215-9D50-67D5185BEEAF</gtr:id><gtr:title>Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c733e8bf1e172edfe903712bbf934b9"><gtr:id>5c733e8bf1e172edfe903712bbf934b9</gtr:id><gtr:otherNames>Elphick D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>C418D2ACF50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E6B574F-C9CE-4007-987C-2076F42E9985</gtr:id><gtr:title>Primary human colonic myofibroblasts are resistant to Clostridium difficile toxin A-induced, but not toxin B-induced, cell death.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ecd2775862de0442e3e7624c0876149"><gtr:id>2ecd2775862de0442e3e7624c0876149</gtr:id><gtr:otherNames>Mullan N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>MwsCQVQUruU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95C4B0AE-463E-4420-A17E-B6CD1433B517</gtr:id><gtr:title>The stem cells of small intestinal crypts: where are they?</gtr:title><gtr:parentPublicationTitle>Cell proliferation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/881f24b40b756de7f6aea898d226c07f"><gtr:id>881f24b40b756de7f6aea898d226c07f</gtr:id><gtr:otherNames>Potten CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-7722</gtr:issn><gtr:outcomeId>4CA604655C2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CCC0E53-C03E-4110-A378-C6B7B279205D</gtr:id><gtr:title>Effects of Trichinella spiralis infection on intestinal pathology in mice lacking interleukin-4 (IL-4) or intestinal trefoil factor (ITF/TFF3).</gtr:title><gtr:parentPublicationTitle>Parasitology international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6951cbf97511658ea20c20c456d70668"><gtr:id>6951cbf97511658ea20c20c456d70668</gtr:id><gtr:otherNames>Dehlawi MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1383-5769</gtr:issn><gtr:outcomeId>F9148389231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>064F37B7-D9FB-495C-8BE0-B4F91DE91CC1</gtr:id><gtr:title>Recent advances in Clostridium difficile-associated disease.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8ff04bdc0e3296c6ebbdf9e68457119"><gtr:id>f8ff04bdc0e3296c6ebbdf9e68457119</gtr:id><gtr:otherNames>Monaghan T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>42E9ECFCFB9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FCCE696-A02D-4BA4-A1E6-B00361BB0697</gtr:id><gtr:title>Expression profiling of Wnt family of genes in normal and inflammatory bowel disease primary human intestinal myofibroblasts and normal human colonic crypt epithelial cells.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b75403f60e5d6fe73258a2f20e3bc889"><gtr:id>b75403f60e5d6fe73258a2f20e3bc889</gtr:id><gtr:otherNames>Hughes KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>gTtvuvAThbL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F35A316-FB4F-4C27-AD7E-2FCED6605E9C</gtr:id><gtr:title>Heterogeneity in histone 2B-green fluorescent protein-retaining putative small intestinal stem cells at cell position 4 and their absence in the colon.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b75403f60e5d6fe73258a2f20e3bc889"><gtr:id>b75403f60e5d6fe73258a2f20e3bc889</gtr:id><gtr:otherNames>Hughes KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn><gtr:outcomeId>pm_15823_23_22997199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D96E3021-8BD2-4C5C-9F2F-C291386A33E5</gtr:id><gtr:title>Characterization of putative stem cells in isolated human colonic crypt epithelial cells and their interactions with myofibroblasts.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Cell physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b81c715dd51ad09e2ac2f436477a46c3"><gtr:id>b81c715dd51ad09e2ac2f436477a46c3</gtr:id><gtr:otherNames>Samuel S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0363-6143</gtr:issn><gtr:outcomeId>A71079ADECE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27198D36-C5D8-4A9E-8858-5A5F4E74F33F</gtr:id><gtr:title>Alteration in human defensin-5 expression following gastric bypass surgery.</gtr:title><gtr:parentPublicationTitle>Journal of clinical pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e72ae9d7c9645e2ff961b3adf2d42a79"><gtr:id>e72ae9d7c9645e2ff961b3adf2d42a79</gtr:id><gtr:otherNames>Sundbom M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9746</gtr:issn><gtr:outcomeId>9C6638B7165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B719416E-E204-4E2D-BDCC-0FD5C83B65F0</gtr:id><gtr:title>Regional differences in stem and transit cell proliferation and apoptosis in the terminal ileum and colon of mice after 12 Gy.</gtr:title><gtr:parentPublicationTitle>International journal of radiation oncology, biology, physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92935dea4f2aad0172575a7444280c53"><gtr:id>92935dea4f2aad0172575a7444280c53</gtr:id><gtr:otherNames>G?ndara RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0360-3016</gtr:issn><gtr:outcomeId>pm_15823_23_22196132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09D17DF9-3DDA-47D5-A1FB-34FDB72E05DD</gtr:id><gtr:title>Determination of Histone 2B-Green Fluorescent Protein (GFP) Retention in Intestinal Stem Cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b75403f60e5d6fe73258a2f20e3bc889"><gtr:id>b75403f60e5d6fe73258a2f20e3bc889</gtr:id><gtr:otherNames>Hughes KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5a8580a68ecc59.34300180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A08FD70C-D2C4-43DB-9A43-2807AA4F53D0</gtr:id><gtr:title>Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bded6cec3cbccb32e8a38c14ec7d97ba"><gtr:id>bded6cec3cbccb32e8a38c14ec7d97ba</gtr:id><gtr:otherNames>Sutton PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>7D076F2F2E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>776AC481-4FA9-4CB7-970E-99C9E4B782F9</gtr:id><gtr:title>Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2df6cf0e44bda3035674f81d473ebf19"><gtr:id>2df6cf0e44bda3035674f81d473ebf19</gtr:id><gtr:otherNames>Brown M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>5461bc32992ec9.53489495</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500067</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>